Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2026-02-19 @ 11:19 PM
Study NCT ID:
NCT02961257
Status:
COMPLETED
Last Update Posted:
2022-05-12
First Post:
2016-08-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel
Sponsor:
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CABASTY
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None